Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany.

Krumbholz A, Neubert A, Girschick H, Huppertz HI, Kaiser P, Liese J, Streng A, Niehues T, Peters J, Sauerbrey A, Schroten H, Tenenbaum T, Wirth S, Sauerbrei A.

Med Microbiol Immunol. 2013 Dec;202(6):417-24. doi: 10.1007/s00430-013-0303-4. Epub 2013 Jun 29.

PMID:
23812435
2.

Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.

Joshi N, Yr NK, Kumar A.

Trop Gastroenterol. 2000 Apr-Jun;21(2):63-5.

PMID:
10881625
3.

Changing epidemiology of hepatitis A infection in Izmir, Turkey.

Kurugol Z, Aslan A, Turkoglu E, Koturoglu G.

Vaccine. 2011 Aug 26;29(37):6259-61. doi: 10.1016/j.vaccine.2011.06.069. Epub 2011 Jul 18.

PMID:
21763745
4.

Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.

Lazcano-Ponce E, Conde-Gonzalez C, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E.

Hum Vaccin Immunother. 2013 Feb;9(2):375-81. Epub 2013 Jan 4.

5.

Hepatitis a in Lebanon: a changing epidemiological pattern.

Sacy RG, Haddad M, Baasiri G, Khoriati A, Gerbaka BJ, Abu-Elyazeed R.

Am J Trop Med Hyg. 2005 Aug;73(2):453-6.

PMID:
16103621
6.

Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea.

Chung SJ, Kim TY, Kim SM, Roh M, Yu MY, Lee JH, Oh C, Lee EY, Lee S, Jeon YC, Yoo KS, Sohn JH.

Clin Mol Hepatol. 2014 Jun;20(2):162-7. doi: 10.3350/cmh.2014.20.2.162. Epub 2014 Jun 30.

7.

Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine.

Moisseeva AV, Marichev IL, Biloschitchkay NA, Pavlenko KI, Novik LV, Kovinko LV, Lyabis OI, Houillon G, Rasuli AM.

J Viral Hepat. 2008 Oct;15 Suppl 2:43-6. doi: 10.1111/j.1365-2893.2008.01028.x.

PMID:
18837833
9.

A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates.

Lee D, Ki M, Lee A, Lee KR, Park HB, Kim CS, Yoon BY, Kim JH, Lee YS, Jeong SH.

Korean J Hepatol. 2011 Mar;17(1):44-50. doi: 10.3350/kjhep.2011.17.1.44.

10.

Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.

Zhu Y, Yuan Z, Zhao Q, Chen G, Xu B.

Epidemiol Infect. 2013 Mar;141(3):556-62. doi: 10.1017/S0950268812001161. Epub 2012 Jun 12.

PMID:
22687628
11.

Age-specific seroprevalence of hepatitis A in Antananarivo (Madagascar).

Raharimanga V, Carod JF, Ramarokoto CE, Chrétien JB, Rakotomanana F, Talarmin A, Richard V.

BMC Infect Dis. 2008 Jun 6;8:78. doi: 10.1186/1471-2334-8-78.

12.

Decreasing immunity to hepatitis A virus infection among US adults: Findings from the National Health and Nutrition Examination Survey (NHANES), 1999-2012.

Klevens RM, Denniston MM, Jiles-Chapman RB, Murphy TV.

Vaccine. 2015 Nov 17;33(46):6192-8. doi: 10.1016/j.vaccine.2015.10.009. Epub 2015 Oct 23.

PMID:
26476364
13.

Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift.

Moon HW, Cho JH, Hur M, Yun YM, Choe WH, Kwon SY, Lee CH.

World J Gastroenterol. 2010 Mar 7;16(9):1115-8.

14.

Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil.

Vitral CL, Ospina FL, Artimos S, Melgaço JG, Cruz OG, de Paula VS, Luz SB, Freire M, Gaspar LP, Amado LA, Engstrom EM, Fortes CD, Souza TC, Dias MN, Gaspar AM, Souto FJ.

Mem Inst Oswaldo Cruz. 2012 Aug;107(5):652-8.

15.

The changing pattern of hepatitis A in Lebanese adults.

Melhem NM, Jaffa M, Zaatari M, Awada H, Salibi NE, Ramia S.

Int J Infect Dis. 2015 Jan;30:87-90. doi: 10.1016/j.ijid.2014.10.007. Epub 2014 Oct 30.

16.

Shifting susceptibility to hepatitis A among children and adolescents over the past decade.

Krebs LS, Ranieri TM, Kieling CO, Ferreira CT, Silveira TR.

J Pediatr (Rio J). 2011 May-Jun 8;87(3):213-8. doi: doi:10.2223/JPED.2088. Epub 2011 Apr 5. English, Portuguese.

17.

Impact of recurrent epidemics of hepatitis a virus infection on population immunity levels: Bristol Bay, Alaska.

Peach D, McMahon BJ, Bulkow L, Funk E, Harpaz R, Margolis HS.

J Infect Dis. 2002 Oct 15;186(8):1081-5. Epub 2002 Sep 20.

PMID:
12355357
18.

Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.

Al-Aziz AM, Awad MA.

East Mediterr Health J. 2008 Sep-Oct;14(5):1028-35.

PMID:
19161074
19.

[Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].

Chlíbek R, Cecetková B, Smetana J, Prymula R, Kohl I.

Epidemiol Mikrobiol Imunol. 2006 Aug;55(3):99-104. Czech.

PMID:
16970073
20.

Hepatitis A seroprevalence in public school children in Campos dos Goytacazes, Rio de Janeiro State, Brazil, prior to the introduction of the hepatitis A universal childhood vaccination.

Kury CM, Pinto MA, Silva JP, Cruz OG, Vitral CL.

Cad Saude Publica. 2016 Nov 1;32(11):e00175614. doi: 10.1590/0102-311X00175614.

Supplemental Content

Support Center